Gene therapy for blindness to cost $850,000

EURONEWS | on Wed, Jan 3, 4:13 PM

A new gene therapy to treat progressive blindness will cost $850,000, the company that makes it said Wednesday. But the company has laid groundwork for innovative ways to pay for the drug by securing deals with an insurance company, a pharmacy benefit manager and negotiating with the federal government. The company hopes its $425,000-per-eye treatment may eventually lead to new ways to pay for extremely expensive new therapies. Luxturna was just approved by the Food and Drug Administration la...

Read the full article

Semantic processing powered by OpenCalais

Use of the DailyMe service and DailyMe web site constitutes acceptance of the Company's Terms of Service and Privacy Policy.

© 2018 DailyMe, Inc. All rights reserved.